MilliporeSigma
Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test
The diagnostic is composed of Agilent's Bravo automation workstation and Mammoth's DETECTR BOOST SARS-CoV-2 assay.
Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company
The CRISPR-based test uses Mammoth's DETECTR BOOST platform and will be compatible with both nasal swab and saliva samples.
10x Genomics, MilliporeSigma Collaborate on CRISPR Screening Workflow
The firms are targeting a compatible offering for single-cell gene expression screens following CRISPR-based editing, with applications in drug discovery.
The company's CRISPR-chrom technology fuses chromatin-modulating peptides to CRISPR nucleases, essentially moving chromatin out of the way for more efficient editing.
MilliporeSigma Licenses CRISPR Tech to Promega
Promega said it plans to use the technology to create new research products for investigating endogenous biology.
Apr 11, 2017
May 19, 2016
Nov 18, 2015
Merck KGaA Completes $17B Sigma-Aldrich Acquisition
Oct 29, 2015
Sigma-Aldrich Acquiring Olink's Duolink Line
Aug 11, 2015
Brazil Clears Merck KGaA's Buy of Sigma-Aldrich
Jul 30, 2015
Currency Effects Trim Sigma-Aldrich Q2 Sales
Jul 23, 2015